Furthermore, the dysregulation and upregulation of PRMT5 in several cardiovascular disorders [75] and neurological disorders [80,84] raise the question of how PRMT5 may be therapeutically targeted for disease treatment. This evidence concerns the gene PRMT5 and cardiovascular disorder.